Lv1
88 积分 2022-05-21 加入
GPCR drug discovery: new agents, targets and indications
3个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
3个月前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
3个月前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
3个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
4个月前
已完结
抑郁症病因学和治疗学的研究进展
5个月前
已完结
Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma
1年前
已完结
Molecular glue CELMoD compounds are regulators of cereblon conformation
1年前
已完结
Essential role of interferon regulatory factor 4 (IRF4) in immune cell development
1年前
已完结
IRF4 in multiple myeloma—Biology, disease and therapeutic target
1年前
已完结